Urinary heparan sulphate is increased in normoalbuminuric diabetic patients

Medicina

Volumn 60, Issue 2, 2000, Pages 195-201

  Elbert, Alicia E ^a   Paglione, Ana Maria ^a   Bragagnolo, Julio C ^a   Mainetti, Hector A ^a   Bonavita, Carla D ^a   Ruiz, Maximino ^a  

^a NONE

Author keywords

Diabetes; Heparan sulphate; Normoalbuminuria

Indexed keywords

HEPARAN SULFATE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MIDDLE AGED; SEX DIFFERENCE; URINE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEPARITIN SULFATE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0040442230     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty one. Diabetologia 1987; 14: 371-4.
2. Viberti GC. Recent advances in understanding mechanisms and natural history of diabetic renal disease. Diabetes Care 1988; 11 (Suppl 1): 3-9.
3. The USRDS 1995 Annual Data. Report III. Incidence and causes of treated ESRD. Am J Kidney Dis 1995; 26 (Suppl 2): 539-50.
4. The USRDS 1995 Annual Data. Report II. Prevalence of ESRD therapy. Am J Kidney Dis 1995; 26 (Suppl 2): 530-8.
5. Almad T, Kirsten N, Feldt-Rasmussen B, Deckert T. The predictive value of microalbuminuria in IDDM. Diabetes Care 1994; 17: 120-4.
6. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney int 1987; 31: 673-89.
7. Luetscher JA, Kralmer F. Microalbuminuria and increased plasma prorenin. Arch Int Med 1988; 148: 937-41.
8. Trevisan R, Nosadini R, Fioretto P, Semplicini A, Donado V, Doria A, et al. Clustering of risk factors in hypertensive insulin dependent diabetics with high sodium-lithium countertransport. Kidney Int 1992; 41: 855-61.
9. Craig Tisher C, Madsen KM. Anatomy of the kidney. In: Brenner BM, Rector FC, eds. The Kidney. 5th edn. Philadelphia: WB Saunders, 1996; 1-71.
10. Tamsma JT, Van Der Bom JF, Bruijn AJ, Assmann JK, Weening JJ. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in glomerular basement membrane. Diabetologia 1994; 37: 313-20.
11. Van Der Bom J, Lambert PWJ, Bakker M, Veerkamp HJ. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115-23.
12. Olgemoller L, Schwaabe S, Gertitz D, Schleicher L. Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia 1992; 35: 183-6.
13. Tamsma JT, Van Der Woude FJ, Lemkes HHPJ. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrol Dial Transplant 1996; 11:182-5.
14. Deckert T, Feldt Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin dependent diabetes mellitus. Kidney Int 1988; 33: 100-6.
15. Saxena U, Klein MG, Goldberg U. Identification and characterization of the endothelial cell surface lipoprotein lipase receptor. J Biol Chem 1991; 266: 17516-21.
16. Deckert T, Feldt Rasmussen B, Borch Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno Hypothesis. Diabetologia 1989, 32: 219-26.
17. Reddi AS. Glomerular and urinary glycosaminoglycans in diabetic rats. Clinica Chimica Acta 1990; 189: 211-20.
18. McAuliffe VV, Fisher EJ, McLennan SV, Yue DK, Turtle JR. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminuria. Diabet Med 1996; 13:758-63.
19. Shield JH, Carradus M, Stone JE, Hunt LP, Baum JD, Pennock CA. Urinary heparan sulphate proteoglycan excretion is abnormal in insulin dependent diabetes. Ann Clin Biochem 1995; 32: 557-60.
20. Craddock JG, Kerby GP, Durham NC. Urinary excretion of acid mucopolysaccharides by diabetic patients. J Lab and Clinic Med 1955; 46: 193-8.
21. Lubec G, Legenstein E, Pollak A, Meznik E. Glomerular basement membrane charges, Hb A1c and urinary excretion of acid glycosaminoglycans in children with diabetes mellitus. Clinica Chimica Acta 1980; 103: 45-9.
22. Bonavita N, Reed P, Donnelly PV, Hill LL, Differante N. The urinary excretion of heparan sulfate by juvenile and adult onset diabetic patients. Connective Tissue Research 1984; 13: 83-7.
23. Baggio B, Briani G, Cicerello E, Gambaro G, Bruttomesso D, Tiengo A, et al. Urinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in nonalbuminuric diabetic patients. Nephron 1986; 43: 187-90.
24. Perez Blanco F, Moreno Terribas G, Cantero Hinojosa J, Rodriguez Cuartero A. Urinary excretion of glycosaminoglycans in patients with early diabetic nephropathy (Letter). Nephron 1996; 73: 344-5.
25. Report of the Expert Committe on the diagnosis and classification of Diabetes Mellitus. The Expert Committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl 1) S5-S19.
26. Lagunoff D, Warren G. Determination of 2-deoxy-2-sulfoaminohexose content of mucopolysaccharides. Arch Bioch & Biophys 1962; 99: 392-400.
27. Smith RL, Gilkerson E. Quantitation of glycosaminoglycan hexosamine using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Analyt Biochem 1979; 98: 478-80.
28. Viberti GC, Mogensen CE, Keen H, Jacobsen FK, Jarrett RJ, Christensen CK. Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest 1982; 42: 147-57.
29. Stroten A. A micromethod for creatinine using resin to remove interfering substances. J Clin Lab Technol 1968; 25: 240-4.
30. Kofoed-Enevoldsen A, Borch Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of proteinuria in type I diabetic patients in Denmark. Diabetes 1987; 2: 205-9.
31. Mogensen CE, Keane WF, Bennett PM, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-4.
32. Mathiesen ER, Oxenboll B, Johanden K, Svenchsen PA, Deckert T. Incipient nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406-10.
33. Borch Johnsen K, Krag Andersen P, Deckert T. The effect of proteinuria on relative mortality in IDDM. Diabetologia 1985; 28:590-6.
34. Barbosa J. Concordance for nephropathy in diabetic siblings: Evidence of genetic susceptibility to diabetic kidney disease (Abstract). Diabetes 1987; 36 (suppl): 105A.
35. Kanwar YS, Veis A, Kumura JM, Jakuboswsky ML. Characterization of heparan sulfate proteoglycan of glomerular basement membranes. Proc Natl Acad Sci USA 1984; 81:762-6.
36. Rohrbach DH, Hassell JR, Kleinman H, Martin GR. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes 1982; 31: 185-8.
37. Reddi AS, Ranamurth M, Miller S, Dhuper S, Lasker N. Enalapril improves albuminuria by preventing glomerular loss of heparan in diabetic rats. Biochem Med Metab Biol 1991; 45: 119-31.
38. Mitsuhashi H, Tsukada Y, Ono K, Yano S, Naruse T. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular disease. Clin Nephrol 1993; 39: 231-7.
39. Tarsio JF, Wigness B, Phade TD, Rupp WM, Buchwald H, Furcht LT. Non enzymatic glycation of fibronectin and alteration in molecular association of cell matrix and basement membrane components in diabetes mellitus. Diabetes 1985; 34: 477-84.
40. Vernier RL, Steffes MW, Sisson Ross S, Mauer SM. Heparan proteoglycan in glomerular basement membrane in type I diabetes mellitus. Kidney Int 1992; 41: 1070-80.
41. Mathieser ER, Ronn B, Yensen T, Storm B, Deckert T. Microalbuminuria precedes elevation in blood pressure in diabetic nephropathy (Abstract). Diabetologia 1988; 31: 519A.
42. Velussi M, Cemigol AM, Dapas F, De Monte A. Glycosaminoglycans oral therapy reduces microalbuminuria, blood fibrinogen levels and limb arteriopathy clinical signs in patients with non-insulin dependent diabetes mellitus. Diab Nutr Metab 1996; 9: 53-8.
43. Kofoed-Enevoldsen A. Heparan sulphate in pathogenesis of diabetic nephropathy. Diabetes Metab Reviews 1995; 11: 137-60.